HAE Haemonetics Corporation Common Stock
$107,00
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 6, 2026
52W-Spanne
$47–$107
99% of range
Analystenbewertung
BUY
15 analysts
Kursziel
$96
P/E (TTM)
52.2
ROE
11.8%
Nettogewinnmarge
7.3%
Über Haemonetics Corporation Common Stock Unternehmensübersicht von Wikipedia
Die Haemonetics Corporation ist ein weltweiter Anbieter von Blut- und Plasmaprodukten und -dienstleistungen. Das Unternehmen wurde in den 1970er Jahren von Dr. Allen (Jack) Latham in Natick, Massachusetts, gegründet. Heute hat das Unternehmen expandiert und verfügt über Niederlassungen in 16 Ländern. Das Unternehmen beschäftigt ca. 3300 Mitarbeiter und vertreibt seine Produkte in über 50 Ländern. Die Einnahmen stammen fast zu gleichen Teilen aus den drei wichtigsten Märkten Asien, Europa und Amerika.
Mehr lesen
Die Haemonetics Corporation ist ein weltweiter Anbieter von Blut- und Plasmaprodukten und -dienstleistungen. Das Unternehmen wurde in den 1970er Jahren von Dr. Allen (Jack) Latham in Natick, Massachusetts, gegründet. Heute hat das Unternehmen expandiert und verfügt über Niederlassungen in 16 Ländern. Das Unternehmen beschäftigt ca. 3300 Mitarbeiter und vertreibt seine Produkte in über 50 Ländern. Die Einnahmen stammen fast zu gleichen Teilen aus den drei wichtigsten Märkten Asien, Europa und Amerika.
Haemonetics belegt Platz 59 der der größten Medizintechnikunternehmen der Welt und ist im S&P 400 vertreten.
Geschichte
Das Unternehmen wurde 1971 gegründet. Haemonetics begann mit der Herstellung von Behältern und Beuteln, die für die Blutentnahme benötigt wurden. Die Latham Bowl war ein Einwegbehälter, der die Trennung von Blut durch Zentrifugation automatisieren konnte. In den 90er Jahren erweiterte das Unternehmen seine Produktlinien und Technologien. Im Jahr 1988 eröffnete das Unternehmen eine Produktionsstätte in Holbrook, Massachusetts.
1995 erwarb das Unternehmen die Produktionsstätte von Intravenous Solutions in Union, South Carolina. Durch weitere Übernahmen wuchs das Unternehmen und erweiterte seine Dienstleistungen. In den folgenden Jahren verzweigte sich das Unternehmen und stellte die gesamte Plasmasammelstation her, einschließlich der Maschine, des Zubehörs und der Software für die Plasmasammlung. Zu diesen Akquisitionen gehörte die in Edmonton ansässige Fifth Dimension (5D) Information Systems, um in die Blut- und Plasmasoftwarebranche einzusteigen.
Weitere Akquisitionen waren die in Chicago ansässige Arryx im Juli 2006, Information Data Management, Inc. im Januar 2007, die Übernahme einer Abteilung von Haemoscope im Jahr 2007, die Übernahme von Infonale im Juli 2007, und 2009 die in Chico, Kalifornien, ansässige Altivation und die in Tucson, Arizona, ansässige Sebra. Am 21. August 2007 wurden 5D und IDM offiziell zu einer neuen Tochtergesellschaft mit dem Namen Haemonetics Software Solutions zusammengeführt. Die Mitarbeiter von Edmonton (5D) und Rosemont (IDM) arbeiten weiterhin in ihren jeweiligen Büros. Weitere Akquisitionen waren die Übernahme von Neoteric Technology Ltd. im April 2009 und die Übernahme von Global Med Technologies, Inc. mit Sitz in Kalifornien im April 2010. Am 1. August 2012 erwarb Haemonetics das Transfusionsmedizin-Geschäft der Pall Corporation für 550 Millionen US-Dollar. Im April 2024 wurde bekannt gegeben, dass Haemonetics die Übernahme des in Chicago ansässigen Herstellers von Temperaturregelungssystemen für medizinische Geräte, Attune Medical, für 160 Millionen US-Dollar abgeschlossen hat.
Verunreinigungen mit Partikeln
Im Juli 2020 entdeckte die Zeit zusammen mit sieben weiteren Medien, dass sich bei bestimmten Plasmaspendemaschinen des Unternehmens bei der Benutzung kleine Partikel aus dem Drehgelenk einer Zentrifuge lösen können und in den Plasmabeutel oder den Körper des Spenders gelangen könnten. Es soll sich dabei vor allem um Aluminiumoxid oder Phenolharz handeln, aus denen das betroffene Drehgelenk besteht.
Produkte
Die Produkte von Haemonetics können in zwei große Kategorien eingeteilt werden. Spenderprodukte (die an die Blutspendeindustrie vermarktet werden und Produkte umfassen, die den Blutspendeprozess automatisieren, die Verarbeitung von Blut automatisieren, die Inaktivierung von Krankheitserregern und den Nachweis von Bakterien im Blut unterstützen und den Hämatokritwert des Blutes testen) und Produkte, die an die Chirurgie vermarktet werden, um den Blutverlust bei Patienten zu kontrollieren. Zu diesen Produkten gehören Geräte für die chirurgische Blutrückgewinnung (sog. Autotransfusion), chirurgische Blutabsaugsysteme und Systeme zur Erwärmung von Blut und Patienten.
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
HAE Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$107.00
Marktkapitalisierung
$4.84B
P/E (TTM)
52.2
EPS (TTM)
$2.05
Umsatz (TTM)
$1.33B
Dividendenrendite
—
ROE
11.8%
Verschuldungsgrad
1.5
52W-Spanne
$47 – $107
HAE Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$1.33B
2017-04-01
→
2026-03-28
EPS
$2.05
2017-04-01
→
2026-03-28
Freier Cashflow
$260M
2017-04-01
→
2026-03-28
Margen
7.3%
2017-04-01
→
2026-03-28
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
HAE
Peer-Median
P/E (TTM)
52.2
39.4
P/S (TTM) (K/V (TTM))
3.6
2.1
P/B (K/B)
6.1
3.3
EV / EBITDA
37.1
—
Price / FCF (Kurs / FCF)
18.6
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
HAE
Peer-Median
Gross Margin (Bruttogewinnmarge)
59.0%
58.7%
Operating Margin (Betriebsgewinnmarge)
11.8%
—
Net Profit Margin (Nettogewinnmarge)
7.3%
-11.8%
ROA
4.0%
-6.3%
ROE
11.8%
-13.4%
ROIC
5.9%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
HAE
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
1.5
37.4
Current Ratio (Liquiditätsgrad)
3.0
2.4
Quick Ratio
1.6
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
HAE
Peer-Median
Revenue YoY (Umsatz YoY)
-2.0%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
4.5%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
8.9%
—
EPS YoY (EPS VjV)
-38.1%
—
Net Income YoY (Nettogewinn YoY)
-42.0%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
HAE
Peer-Median
HAE Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
15 Analysten
- Starker Kauf 5 33,3%
- Kauf 6 40,0%
- Halten 4 26,7%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
10 Analysten · 2026-08-13
Median
$95.50
Über allen Zielen →
$107.00
Tief
$86.00
Hoch
$105.00
Median-Ziel
$95.50
-10,7%
Mittelwert-Ziel
$96.20
-10,1%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.06%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2027 | $1.14 | $1.09 | 0.05% |
| 30. Juni 2026 | $1.14 | $1.09 | 0.05% |
| 31. März 2026 | $1.29 | $1.28 | 0.01% |
| 31. Dezember 2025 | $1.31 | $1.26 | 0.05% |
| 30. September 2025 | $1.27 | $1.12 | 0.15% |
| 30. Juni 2025 | $1.10 | $1.03 | 0.07% |
| 31. März 2025 | $1.24 | $1.23 | 0.01% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| HAE | $2.45B | 26.4 | -2.0% | 7.3% | 11.8% | 59.0% |
| COO | $13.70B | 37.4 | 5.1% | 9.2% | 4.6% | 65.5% |
| ALGN | $11.14B | 27.6 | 0.90% | 10.2% | 10.3% | 67.2% |
| LNTH | $4.30B | 19.5 | 0.50% | 15.2% | 20.7% | 61.1% |
| MMED | $3.71B | -10.2 | 14.2% | -10.7% | -9.3% | 54.2% |
| MMSI | $5.24B | 41.4 | 11.8% | 8.5% | 8.4% | 48.7% |
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | — |
| XRAY | $2.28B | -3.8 | -3.0% | -16.2% | -36.4% | 50.0% |
| NEOG | $1.95B | -224.2 | -2.7% | -0.91% | -0.38% | 46.9% |
| UFPT | $1.71B | 25.4 | 19.5% | 11.3% | 16.9% | 28.3% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.33B | $1.36B | $1.31B | $1.17B | $993M | $870M | $988M | $968M | $904M | $886M | $909M | $910M | |
| Cost of Revenue | $546M | $612M | $618M | $554M | $488M | $473M | $504M | $550M | $492M | $508M | $503M | $476M | |
| Gross Profit | $788M | $749M | $692M | $615M | $506M | $398M | $485M | $418M | $412M | $378M | $406M | $434M | |
| R&D Expense | $60M | $63M | $54M | $50M | $47M | $33M | $31M | $36M | $39M | $38M | $45M | $54M | |
| SG&A Expense | $442M | $437M | $430M | $377M | $340M | $275M | $282M | $273M | $317M | $302M | $317M | $337M | |
| Operating Expenses | $631M | $527M | $527M | $459M | $425M | $308M | $381M | $334M | $356M | $398M | $450M | $394M | |
| Operating Income | $157M | $222M | $165M | $156M | $81M | $90M | $103M | $84M | $56M | $-19M | $-44M | $41M | |
| Other Non-op | $-29M | $-10M | $-13M | $-15M | $-17M | $-17M | $-16M | $-10M | $-5M | $-8M | $-9M | $-9M | |
| Pretax Income | $128M | $212M | $152M | $141M | $64M | $73M | $87M | $74M | $60M | $-27M | $-53M | $31M | |
| Income Tax | $31M | $44M | $34M | $26M | $20M | $-7M | $11M | $19M | $14M | $-1M | $2M | $14M | |
| Net Income | $97M | $168M | $118M | $115M | $43M | $79M | $77M | $55M | $46M | $-26M | $-56M | $17M | |
| EPS (Basic) | $2.06 | $3.33 | $2.32 | $2.27 | $0.85 | $1.57 | $1.51 | $1.07 | $0.86 | $-0.51 | $-1.09 | $0.33 | |
| EPS (Diluted) | $2.05 | $3.31 | $2.29 | $2.24 | $0.84 | $1.55 | $1.48 | $1.04 | $0.85 | $-0.51 | $-1.09 | $0.32 | |
| Shares (Basic) | 47,179,000 | 50,330,000 | 50,706,000 | 50,783,000 | 51,047,000 | 50,688,000 | 50,692,000 | 51,533,000 | 52,755,000 | 51,524,000 | 50,910,000 | 51,533,000 | |
| Shares (Diluted) | 47,354,000 | 50,730,000 | 51,397,000 | 51,420,000 | 51,353,000 | 51,292,000 | 51,815,000 | 52,942,000 | 53,501,000 | 51,524,000 | 50,910,000 | 52,089,000 | |
| EBITDA | $157M | $222M | $165M | $156M | $81M | $90M | $103M | $84M | $56M | $-19M | $-44M | $41M |
Bilanz 25
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $245M | $307M | $179M | $284M | $259M | $192M | $137M | $169M | $180M | $140M | $115M | $161M | |
| Receivables | $217M | $203M | $207M | $179M | $159M | $128M | $165M | $185M | $151M | $153M | $157M | $146M | |
| Inventory | $306M | $365M | $317M | $259M | $293M | $323M | $270M | $194M | $161M | $177M | $187M | $211M | |
| Prepaid Expense | $66M | $60M | $66M | $47M | $44M | $51M | $31M | $27M | $29M | $41M | $29M | $40M | |
| Current Assets | $835M | $935M | $769M | $770M | $756M | $694M | $604M | $576M | $521M | $510M | $488M | $558M | |
| PP&E (Net) | $306M | $284M | $311M | $311M | $258M | $218M | $253M | $344M | $332M | $324M | $338M | $322M | |
| PP&E (Gross) | $842M | $837M | $959M | $944M | $869M | $817M | $832M | $933M | $873M | $807M | $786M | $732M | |
| Accum. Depreciation | $536M | $553M | $648M | $633M | $611M | $600M | $579M | $589M | $541M | $484M | $449M | $410M | |
| Goodwill | $656M | $604M | $565M | $466M | $467M | $466M | $211M | $211M | $211M | $211M | $268M | $334M | |
| Intangibles | $448M | $456M | $406M | $276M | $310M | $365M | $133M | $128M | $157M | $178M | $204M | $245M | |
| Other Non-current Assets | $142M | $164M | $136M | $107M | $63M | $71M | $62M | $12M | $12M | $12M | $14M | $11M | |
| Total Assets | $2.40B | $2.45B | $2.20B | $1.93B | $1.86B | $1.82B | $1.27B | $1.27B | $1.24B | $1.24B | $1.32B | $1.49B | |
| Accounts Payable | $51M | $67M | $73M | $64M | $58M | $50M | $51M | $63M | $55M | $43M | $40M | $48M | |
| Current Liabilities | $283M | $578M | $300M | $252M | $442M | $253M | $275M | $236M | $385M | $211M | $186M | $189M | |
| Capital Leases | $41M | $50M | $58M | $56M | $56M | $63M | $52M | · | · | · | · | · | |
| Deferred Tax | $38M | $63M | $63M | $36M | $29M | $44M | $11M | $20M | $7M | $12M | $21M | $33M | |
| Other Non-current Liabilities | $59M | $68M | $75M | $75M | $80M | $100M | $89M | $29M | $34M | $22M | $26M | $32M | |
| Long-term Debt | $1.24B | $1.22B | $808M | $766M | $774M | $708M | $382M | $350M | $254M | $316M | $408M | $430M | |
| Total Debt | $1.22B | $1.22B | $808M | $766M | $774M | $708M | $382M | $350M | $254M | $315M | $408M | $428M | |
| Common Stock | $453.0K | $482.0K | $508.0K | $504.0K | $511.0K | $509.0K | $503.0K | $510.0K | $523.0K | $523.0K | $509.0K | $517.0K | |
| Retained Earnings | $279M | $352M | $360M | $253M | $202M | $158M | $79M | $161M | $267M | $290M | $316M | $420M | |
| AOCI | $-38M | $-55M | $-36M | $-30M | $-26M | $-30M | $-45M | $-30M | $-19M | $-33M | $-35M | $-22M | |
| Stockholders' Equity | $796M | $821M | $960M | $818M | $749M | $732M | $587M | $668M | $752M | $740M | $722M | $826M | |
| Liabilities + Equity | $2.40B | $2.45B | $2.20B | $1.93B | $1.86B | $1.82B | $1.27B | $1.27B | $1.24B | $1.24B | $1.32B | $1.49B | |
| Shares Outstanding | 45,252,667 | 48,215,899 | 50,787,859 | 50,448,519 | 51,124,240 | 50,868,820 | 50,322,930 | 51,019,918 | 52,342,965 | 52,255,495 | 50,932,348 | 51,670,969 |
Cashflow 16
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $112M | $116M | $97M | $93M | $98M | $84M | $110M | $109M | $89M | $90M | $90M | $86M | |
| Stock-based Comp | $34M | $30M | $28M | $26M | $24M | $26M | $20M | $17M | $13M | $9M | $7M | $14M | |
| Deferred Tax | $-26M | $-6M | $-11M | $6M | $5M | $-21M | $-7M | $13M | $-6M | $-7M | $-1M | $4M | |
| Amort. of Intangibles | $50M | $56M | $41M | $42M | $57M | $41M | $34M | $25M | $32M | $37M | $59M | $34M | |
| Restructuring | $3M | $14M | $14M | $657.0K | $4M | $1M | $4M | $395.0K | $31M | $22M | $23M | $37M | |
| Operating Cash Flow | $293M | $182M | $182M | $273M | $172M | $109M | $158M | $159M | $220M | $160M | $122M | $127M | |
| CapEx | $33M | $39M | $38M | $191M | $97M | $37M | $49M | $119M | $75M | $76M | $102M | $122M | |
| Investing Cash Flow | $-180M | $-162M | $-322M | $-144M | $-86M | $-425M | $-57M | $-116M | $-63M | $-73M | $-105M | $-122M | |
| Debt Issued | · | · | · | · | · | · | $0 | $348M | $0 | $0 | · | $0 | |
| Net Debt Issued | · | $-5M | $-12M | $-10M | $-18M | $-22M | $-13M | $81M | $-62M | $-43M | $-21M | $-9M | |
| Stock Repurchased | $175M | $225M | $0 | $75M | $0 | $0 | $175M | $160M | $100M | $0 | $61M | $39M | |
| Net Stock Activity | $-175M | $-225M | $0 | $-75M | $0 | $0 | $-175M | $-160M | $-100M | $0 | $-61M | $-39M | |
| Financing Cash Flow | $-178M | $109M | $38M | $-100M | $-16M | $367M | $-131M | $-51M | $-121M | $-60M | $-63M | $-33M | |
| Net Change in Cash | $-61M | $128M | $-106M | $25M | $67M | $55M | $-32M | $-11M | $41M | $24M | $-46M | $-32M | |
| Taxes Paid | $61M | · | · | · | · | $12M | $12M | $8M | $9M | $7M | $8M | $11M | |
| Free Cash Flow | $260M | $142M | $115M | $163M | $76M | $72M | $109M | $40M | $146M | $84M | $19M | $5M |
Rentabilität 8
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.0% | 55.0% | 52.8% | 52.6% | 50.9% | 45.7% | 49.0% | 43.1% | 45.6% | 42.7% | 44.7% | 47.7% | |
| Operating Margin | 11.8% | 16.3% | 12.6% | 13.4% | 8.1% | 10.3% | 10.5% | 8.6% | 6.2% | -2.2% | -4.8% | 4.5% | |
| Net Margin | 7.3% | 12.3% | 9.0% | 9.9% | 4.4% | 9.1% | 7.7% | 5.7% | 5.0% | -3.0% | -6.1% | 1.9% | |
| Pretax Margin | 9.6% | 15.6% | 11.6% | 12.1% | 6.4% | 8.4% | 8.8% | 7.6% | 6.6% | -3.1% | -5.9% | 3.4% | |
| EBITDA Margin | 11.8% | 16.3% | 12.6% | 13.4% | 8.1% | 10.3% | 10.5% | 8.6% | 6.2% | -2.2% | -4.8% | 4.5% | |
| ROA | 4.0% | 7.2% | 5.7% | 6.1% | 2.4% | 5.1% | 6.0% | 4.4% | 3.7% | -2.1% | -4.0% | 1.1% | |
| ROE | 11.8% | 19.4% | 12.3% | 14.5% | 5.9% | 11.0% | 13.2% | 8.7% | 6.1% | -3.6% | -7.2% | 2.0% | |
| ROIC | 5.9% | 8.6% | 7.2% | 8.0% | 3.6% | 6.8% | 9.4% | 6.1% | 4.3% | -1.8% | -4.0% | 1.8% |
Liquidität & Solvenz 4
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.0 | 1.6 | 2.6 | 3.1 | 1.7 | 2.7 | 2.2 | 2.4 | 1.4 | 2.4 | 2.6 | 3.0 | |
| Quick Ratio | 1.6 | 0.9 | 1.3 | 1.8 | 0.9 | 1.3 | 1.1 | 1.5 | 0.9 | 1.4 | 1.5 | 1.6 | |
| Debt / Equity | 1.5 | 1.5 | 0.8 | 0.9 | 1.0 | 1.0 | 0.7 | 0.5 | 0.3 | 0.4 | 0.6 | 0.5 | |
| LT Debt / Equity | 1.5 | 1.1 | 0.8 | 0.9 | 0.7 | 0.9 | 0.5 | 0.5 | 0.1 | 0.3 | 0.5 | 0.5 |
Effizienz 3
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.6 | 0.6 | 0.5 | 0.6 | 0.8 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | |
| Inventory Turnover | 1.6 | 1.8 | 2.1 | 2.0 | 1.6 | 1.6 | 2.2 | 3.1 | 2.9 | 2.8 | 2.5 | 2.3 | |
| Receivables Turnover | 6.4 | 6.7 | 6.8 | 6.9 | 6.9 | 5.9 | 5.6 | 5.8 | 5.9 | 5.7 | 6.0 | 5.9 |
Wachstumsraten 9
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -2.0% | 4.0% | 12.0% | 17.7% | 14.1% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 4.5% | 11.1% | 14.6% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -38.1% | 44.5% | 2.2% | 166.7% | -45.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -2.9% | 58.0% | 13.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 5.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -42.0% | 42.6% | 1.9% | 166.1% | -45.4% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -5.5% | 56.9% | 13.9% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 4.1% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.33B | $1.36B | $1.31B | $1.17B | $993M | $870M | $988M | $968M | $904M | $886M | $909M | $910M | |
| Net Income TTM | $97M | $168M | $118M | $115M | $43M | $79M | $77M | $55M | $46M | $-26M | $-56M | $17M | |
| Market Cap | $2.45B | $3.05B | $4.33B | $4.17B | $3.26B | $5.70B | $5.08B | $4.46B | $3.83B | $2.12B | $1.80B | $2.28B | |
| Enterprise Value | $3.42B | $3.96B | $4.96B | $4.66B | $3.78B | $6.21B | $5.33B | $4.64B | $3.90B | $2.30B | $2.09B | $2.55B | |
| P/E | 26.4 | 19.1 | 37.3 | 36.9 | 76.0 | 72.3 | 68.2 | 84.1 | 86.1 | -79.5 | -32.4 | 138.2 | |
| P/S | 1.8 | 2.2 | 3.3 | 3.6 | 3.3 | 6.5 | 5.1 | 4.6 | 4.2 | 2.4 | 2.0 | 2.5 | |
| P/B | 3.1 | 3.7 | 4.5 | 5.1 | 4.4 | 7.8 | 8.7 | 6.7 | 5.1 | 2.9 | 2.5 | 2.8 | |
| P / Tangible Book | · | · | · | 54.9 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 8.3 | 16.8 | 23.8 | 15.3 | 18.9 | 52.4 | 32.1 | 28.0 | 17.4 | 13.3 | 14.7 | 18.0 | |
| P / FCF | 9.4 | 21.4 | 37.5 | 25.6 | 43.1 | 79.4 | 46.4 | 110.7 | 26.3 | 25.4 | 92.4 | 460.7 | |
| EV / EBITDA | 21.8 | 17.9 | 30.1 | 29.8 | 46.8 | 69.2 | 51.5 | 55.6 | 69.5 | -118.4 | -47.6 | 62.9 | |
| EV / FCF | 13.1 | 27.8 | 43.0 | 28.6 | 49.9 | 86.6 | 48.7 | 115.2 | 26.8 | 27.5 | 107.4 | 514.6 | |
| EV / Revenue | 2.6 | 2.9 | 3.8 | 4.0 | 3.8 | 7.1 | 5.4 | 4.8 | 4.3 | 2.6 | 2.3 | 2.8 | |
| Earnings Yield | 3.8% | 5.2% | 2.7% | 2.7% | 1.3% | 1.4% | 1.5% | 1.2% | 1.2% | -1.3% | -3.1% | 0.72% |
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $339M | $346M | $339M | $327M | $321M | $331M | $349M | $346M | $336M | $343M | $336M | $318M | $340M | $305M | $297M | |
| Cost of Revenue | $137M | $148M | $137M | $133M | $129M | $138M | $155M | $158M | $161M | $167M | $158M | $148M | $169M | $147M | $140M | |
| Gross Profit | $203M | $198M | $202M | $195M | $192M | $193M | $194M | $187M | $175M | $176M | $178M | $171M | $172M | $159M | $158M | |
| R&D Expense | $16M | $14M | $14M | $15M | $16M | $18M | $16M | $14M | $14M | $16M | $13M | $13M | $16M | $13M | $11M | |
| SG&A Expense | $119M | $121M | $109M | $102M | $111M | $115M | $106M | $107M | $108M | $109M | $112M | $115M | $98M | $95M | $92M | |
| Operating Expenses | $145M | $221M | $135M | $136M | $138M | $122M | $135M | $136M | $135M | $146M | $132M | $135M | $121M | $115M | $111M | |
| Operating Income | $57M | $-23M | $67M | $58M | $54M | $71M | $59M | $52M | $40M | $30M | $46M | $35M | $51M | $43M | $47M | |
| Other Non-op | $-10M | $-5M | $-7M | $-7M | $-9M | $-598.0K | $-9M | $-7M | $7M | $-7M | $-2M | $-2M | $-3M | $-1M | $-6M | |
| Pretax Income | $48M | $-28M | $60M | $51M | $45M | $71M | $50M | $45M | $47M | $23M | $44M | $33M | $48M | $42M | $41M | |
| Income Tax | $15M | $-8M | $15M | $13M | $11M | $13M | $12M | $11M | $8M | $3M | $13M | $8M | $5M | $9M | $8M | |
| Net Income | $33M | $-20M | $45M | $39M | $34M | $58M | $37M | $34M | $38M | $20M | $31M | $25M | $42M | $33M | $33M | |
| EPS (Basic) | $0.73 | $-0.42 | $0.96 | $0.81 | $0.71 | $1.17 | $0.75 | $0.66 | $0.75 | $0.40 | $0.62 | $0.49 | $0.84 | $0.65 | $0.65 | |
| EPS (Diluted) | $0.72 | $-0.41 | $0.95 | $0.81 | $0.70 | $1.17 | $0.74 | $0.66 | $0.74 | $0.40 | $0.61 | $0.48 | $0.84 | $0.64 | $0.64 | |
| Shares (Basic) | 45,361,000 | -95,314,000 | 46,792,000 | 47,590,000 | 48,111,000 | -101,797,000 | 50,286,000 | 50,898,000 | 50,943,000 | 27,000 | 50,768,000 | 50,727,000 | -102,174,000 | 50,509,000 | 50,953,000 | |
| Shares (Diluted) | 45,704,000 | -95,650,000 | 46,987,000 | 47,664,000 | 48,353,000 | -102,713,000 | 50,639,000 | 51,240,000 | 51,564,000 | 3,000 | 51,445,000 | 51,396,000 | -103,165,000 | 51,219,000 | 51,558,000 | |
| EBITDA | $57M | · | $67M | $58M | $54M | · | $59M | $52M | $40M | · | $46M | $35M | · | $43M | $47M |
Bilanz 25
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $223M | $245M | $363M | $296M | $293M | $307M | $321M | $299M | $344M | $179M | $194M | $351M | · | $224M | $241M | |
| Receivables | $216M | $217M | $196M | $207M | $201M | $203M | $212M | $214M | $201M | $207M | $212M | $174M | · | $181M | $172M | |
| Inventory | $307M | $306M | $321M | $336M | $361M | $365M | $360M | $382M | $374M | $317M | $304M | $286M | · | $256M | $255M | |
| Prepaid Expense | $65M | $66M | $63M | $60M | $59M | $60M | $113M | $61M | $59M | $66M | $55M | $55M | · | $45M | $48M | |
| Current Assets | $811M | $835M | $944M | $900M | $913M | $935M | $1.01B | $956M | $979M | $769M | $765M | $866M | · | $706M | $716M | |
| PP&E (Net) | $304M | $306M | $297M | $292M | $287M | $284M | $286M | $300M | $302M | $311M | $319M | $308M | · | $313M | $308M | |
| PP&E (Gross) | $854M | $842M | $837M | $815M | $795M | $837M | $867M | $939M | $949M | $959M | $979M | $950M | · | · | · | |
| Accum. Depreciation | $550M | $536M | $540M | $523M | $508M | $553M | $581M | $639M | $647M | $648M | $661M | $642M | · | · | · | |
| Goodwill | $657M | $656M | $607M | $606M | $607M | $604M | $605M | $616M | $613M | $565M | $555M | $465M | $466M | $466M | $465M | |
| Intangibles | $435M | $448M | $420M | $428M | $451M | $456M | $466M | $488M | $495M | $406M | $429M | $251M | · | $284M | $293M | |
| Other Non-current Assets | $150M | $142M | $216M | $208M | $196M | $164M | $160M | $156M | $142M | $136M | $127M | $117M | · | $103M | $80M | |
| Total Assets | $2.37B | $2.40B | $2.49B | $2.44B | $2.46B | $2.45B | $2.53B | $2.53B | $2.54B | $2.20B | $2.20B | $2.01B | · | $1.88B | $1.87B | |
| Accounts Payable | $56M | $51M | $49M | $62M | $46M | $67M | $63M | $69M | $77M | $73M | $57M | $80M | · | $64M | $61M | |
| Current Liabilities | $263M | $283M | $540M | $548M | $531M | $578M | $253M | $274M | $260M | $300M | $262M | $264M | · | $227M | $262M | |
| Capital Leases | · | $41M | · | · | · | $50M | · | · | · | $58M | · | · | · | · | · | |
| Deferred Tax | $39M | $38M | $56M | $58M | $59M | $63M | $61M | $63M | $65M | $63M | $62M | $35M | · | $40M | $36M | |
| Other Non-current Liabilities | $57M | $59M | $64M | $66M | $68M | $68M | $90M | $90M | $92M | $75M | $76M | $70M | · | $78M | $78M | |
| Long-term Debt | $1.19B | $1.24B | $1.22B | $1.22B | $1.22B | $1.25B | $1.22B | $1.22B | $1.22B | $808M | $871M | $762M | · | $767M | $818M | |
| Total Debt | $1.17B | · | $1.22B | $1.22B | $1.22B | · | $1.22B | $1.22B | $1.22B | · | $871M | $762M | · | $767M | $818M | |
| Common Stock | $455.0K | $453.0K | $468.0K | $467.0K | $482.0K | $482.0K | $502.0K | $504.0K | $512.0K | $508.0K | $508.0K | $507.0K | · | $504.0K | $506.0K | |
| Retained Earnings | $312M | $279M | $381M | $336M | $356M | $352M | $392M | $369M | $387M | $360M | $340M | $309M | · | $224M | $204M | |
| AOCI | $-42M | $-38M | $-35M | $-41M | $-36M | $-55M | $-56M | $-35M | $-43M | $-36M | $-24M | $-33M | · | $-36M | $-40M | |
| Stockholders' Equity | $837M | $796M | $911M | $849M | $882M | $821M | $907M | $879M | $905M | $960M | $943M | $894M | $818M | $776M | $729M | |
| Liabilities + Equity | $2.37B | $2.40B | $2.49B | $2.44B | $2.46B | $2.45B | $2.53B | $2.53B | $2.54B | $2.20B | $2.20B | $2.01B | · | $1.88B | $1.87B | |
| Shares Outstanding | 45,471,313 | 45,252,667 | 46,829,249 | 46,747,381 | 48,158,723 | 48,215,899 | 50,235,051 | 50,381,127 | 51,152,886 | 50,787,859 | 50,785,040 | 50,740,389 | · | 50,444,470 | 50,605,499 |
Cashflow 13
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $27M | $27M | $27M | $28M | $29M | $28M | $29M | $29M | $29M | $28M | $24M | · | $24M | $24M | · | |
| Stock-based Comp | $9M | $9M | $8M | $8M | $9M | $7M | $8M | $7M | $8M | $7M | $7M | · | $7M | $7M | · | |
| Deferred Tax | $668.0K | $-20M | $-2M | $-725.0K | $-3M | $3M | $-2M | $-2M | $-4M | $-6M | $-3M | · | · | · | · | |
| Amort. of Intangibles | $12M | $12M | $12M | $13M | $13M | $13M | $14M | $14M | $14M | $13M | $9M | $9M | $15M | $10M | $11M | |
| Restructuring | $2M | $196.0K | $1M | $204.0K | $1M | $984.0K | $4M | $5M | $5M | $6M | $8M | $86.0K | $701.0K | $44.0K | $165.0K | |
| Operating Cash Flow | $52M | $71M | $94M | $111M | $17M | $117M | $44M | $49M | $-27M | $64M | $-540.0K | · | $80M | $64M | · | |
| CapEx | $8M | $18M | $6M | $5M | $4M | $16M | $9M | $9M | $6M | $7M | $-3M | · | $93M | $17M | · | |
| Investing Cash Flow | $-22M | $-87M | $-29M | $-30M | $-33M | $18M | $-17M | $-23M | $-139M | $-13M | $-269M | · | $-18M | $-36M | · | |
| Net Debt Issued | $-2M | · | · | · | $-2M | · | · | · | $-2M | · | · | · | · | · | · | |
| Stock Repurchased | · | $100M | $0 | · | · | $150M | $0 | · | · | $0 | $0 | · | $0 | $0 | · | |
| Financing Cash Flow | $-52M | $-101M | $2M | $-77M | $-2M | $-151M | $1M | $-75M | $334M | $-64M | $109M | · | $-2M | $-50M | · | |
| Net Change in Cash | $-22M | $-118M | $67M | $4M | $-14M | $-14M | $22M | $-45M | $166M | $-15M | $-157M | · | $60M | $-17M | · | |
| Free Cash Flow | $44M | · | · | · | $14M | · | · | · | $-33M | · | · | · | · | · | · |
Rentabilität 8
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 59.8% | · | 59.7% | 59.5% | 59.8% | · | 55.5% | 54.2% | 52.0% | · | 52.9% | 53.6% | · | 52.0% | 53.1% | |
| Operating Margin | 16.9% | · | 19.9% | 17.9% | 16.8% | · | 16.9% | 15.0% | 11.8% | · | 13.7% | 11.1% | · | 14.2% | 15.7% | |
| Net Margin | 9.7% | · | 13.2% | 11.8% | 10.6% | · | 10.8% | 9.8% | 11.4% | · | 9.3% | 7.8% | · | 10.8% | 11.2% | |
| Pretax Margin | 14.0% | · | 17.7% | 15.7% | 14.1% | · | 14.3% | 12.9% | 13.9% | · | 13.1% | 10.3% | · | 13.8% | 13.8% | |
| EBITDA Margin | 16.9% | · | 19.9% | 17.9% | 16.8% | · | 16.9% | 15.0% | 11.8% | · | 13.7% | 11.1% | · | 14.2% | 15.7% | |
| ROA | 1.4% | · | 1.8% | 1.6% | 1.4% | · | 1.6% | 1.5% | 1.7% | · | 1.5% | 1.3% | · | 1.8% | 1.8% | |
| ROE | 3.8% | · | 4.9% | 4.5% | 3.8% | · | 4.0% | 3.8% | 4.3% | · | 3.6% | 3.1% | · | 4.4% | 4.7% | |
| ROIC | 2.0% | · | 2.4% | 2.1% | 1.9% | · | 2.1% | 1.9% | 1.5% | · | 1.8% | 1.6% | · | 2.2% | 2.4% |
Liquidität & Solvenz 4
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.1 | · | 1.7 | 1.6 | 1.7 | · | 4.0 | 3.5 | 3.8 | · | 2.9 | 3.3 | · | 3.1 | 2.7 | |
| Quick Ratio | 1.7 | · | 1.0 | 0.9 | 0.9 | · | 2.1 | 1.9 | 2.1 | · | 1.5 | 2.0 | · | 1.8 | 1.6 | |
| Debt / Equity | 1.4 | · | 1.3 | 1.4 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 0.9 | 0.9 | · | 1.0 | 1.1 | |
| LT Debt / Equity | 1.4 | · | 1.0 | 1.1 | 1.0 | · | 1.3 | 1.4 | 1.3 | · | 0.9 | 0.8 | · | 1.0 | 1.0 |
Effizienz 3
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.1 | · | 0.2 | 0.2 | · | 0.2 | 0.2 | |
| Inventory Turnover | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.5 | · | 0.5 | 0.5 | |
| Receivables Turnover | 1.6 | · | 1.7 | 1.6 | 1.6 | · | 1.6 | 1.8 | 1.8 | · | 1.7 | 1.8 | · | 1.8 | 1.9 |
Bewertung (TTM) 14
| Kennzahl | Trend | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1.33B | · | $1.34B | $1.34B | $1.35B | · | $1.37B | $1.34B | $1.30B | · | $1.27B | $1.23B | · | · | · | |
| Net Income TTM | $150M | · | $155M | $144M | $144M | · | $141M | $128M | $136M | · | $130M | $132M | · | · | · | |
| Market Cap | $3.51B | · | $3.76B | $2.25B | $3.55B | · | $3.90B | $4.02B | $4.23B | · | $4.34B | $4.55B | · | $3.97B | $3.75B | |
| Enterprise Value | $4.47B | · | $4.62B | $3.18B | $4.49B | · | $4.80B | $4.95B | $5.11B | · | $5.02B | $4.96B | · | $4.51B | $4.32B | |
| P/E | 24.3 | · | 25.1 | 16.6 | 26.0 | · | 28.2 | 32.0 | 31.5 | · | 33.8 | 35.0 | · | · | · | |
| P/S | 2.6 | · | 2.8 | 1.7 | 2.6 | · | 2.9 | 3.0 | 3.3 | · | 3.4 | 3.7 | · | · | · | |
| P/B | 4.2 | · | 4.1 | 2.7 | 4.0 | · | 4.3 | 4.6 | 4.7 | · | 4.6 | 5.1 | · | 5.1 | 5.1 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | 25.6 | · | 155.7 | · | |
| P / Cash Flow | 67.2 | · | · | · | 204.3 | · | · | · | -154.3 | · | · | · | · | · | · | |
| P / FCF | 79.1 | · | · | · | 260.5 | · | · | · | -127.9 | · | · | · | · | · | · | |
| EV / EBITDA | 77.7 | · | 68.6 | 54.4 | 83.3 | · | 81.3 | 95.7 | 128.6 | · | 109.2 | 140.4 | · | 104.2 | 92.5 | |
| EV / FCF | 100.5 | · | · | · | 328.9 | · | · | · | -154.5 | · | · | · | · | · | · | |
| EV / Revenue | 3.4 | · | 3.5 | 2.4 | 3.3 | · | 3.5 | 3.7 | 3.9 | · | 3.9 | 4.0 | · | · | · | |
| Earnings Yield | 4.1% | · | 4.0% | 6.0% | 3.9% | · | 3.5% | 3.1% | 3.2% | · | 3.0% | 2.9% | · | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2026-03-28 | 2025-03-29 | 2024-03-30 | 2023-04-01 | 2022-04-02 | |
|---|---|---|---|---|---|
| Umsatz | $1.33B | $1.36B | $1.31B | $1.17B | $993M |
| Bruttogewinnmarge % | 59.0% | 55.0% | 52.8% | 52.6% | 50.9% |
| Betriebsgewinnmarge % | 11.8% | 16.3% | 12.6% | 13.4% | 8.1% |
| Nettoergebnis | $97M | $168M | $118M | $115M | $43M |
| Verwässerte EPS | $2.05 | $3.31 | $2.29 | $2.24 | $0.84 |
Bilanz
| 2026-03-28 | 2025-03-29 | 2024-03-30 | 2023-04-01 | 2022-04-02 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 1.5 | 1.5 | 0.8 | 0.9 | 1.0 |
| Liquiditätsgrad | 3.0 | 1.6 | 2.6 | 3.1 | 1.7 |
| Quick Ratio | 1.6 | 0.9 | 1.3 | 1.8 | 0.9 |
Cashflow
| 2026-03-28 | 2025-03-29 | 2024-03-30 | 2023-04-01 | 2022-04-02 | |
|---|---|---|---|---|---|
| Freier Cashflow | $260M | $142M | $115M | $163M | $76M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 363 Einreicher · $2.6B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 61 (+8 vs. Vorquartal) | 42 (-14 vs. Vorquartal) | 108 (-4 vs. Vorquartal) | 112 (-2 vs. Vorquartal) | +6.3M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $349.945.961 | 4.366.138 | 13,44% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $308.172.249 | 4.108.761 | 11,84% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $190.979.550 | 2.546.394 | 7,34% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $154.468.350 | 2.059.578 | 5,93% | Aktien |
| STATE STREET CORP | $136.363.950 | 1.818.186 | 5,24% | Aktien |
| CITADEL ADVISORS LLC | $113.259.000 | 1.510.120 | 4,35% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $109.143.975 | 1.455.253 | 4,19% | Aktien |
| River Road Asset Management, LLC | $96.420.150 | 1.285.602 | 3,70% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $86.651.325 | 1.155.351 | 3,33% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $79.315.930 | 1.057.321 | 3,05% | Aktien |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $62.319.375 | 830.925 | 2,39% | Aktien |
| GOLDMAN SACHS GROUP INC | $52.644.150 | 701.922 | 2,02% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $44.356.725 | 591.423 | 1,70% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $42.780.975 | 570.413 | 1,64% | Aktien |
| Holocene Advisors, LP | $41.264.625 | 550.195 | 1,58% | Aktien |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | $37.034.909 | 493.796 | 1,42% | Aktien |
| North Peak Capital Management, LLC | $25.730.775 | 343.077 | 0,99% | Aktien |
| LONDON CO OF VIRGINIA | $25.543.299 | 340.574 | 0,98% | Aktien |
| DEUTSCHE BANK AG\ | $25.282.575 | 337.101 | 0,97% | Aktien |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $24.905.625 | 332.075 | 0,96% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $24.779.850 | 330.398 | 0,95% | Aktien |
| Boston Trust Walden Corp | $24.170.475 | 322.273 | 0,93% | Aktien |
| Aristotle Capital Boston, LLC | $21.721.809 | 289.624 | 0,83% | Aktien |
| MIZUHO MARKETS AMERICAS LLC | $21.166.050 | 282.214 | 0,81% | Aktien |
| BANK OF AMERICA CORP /DE/ | $20.122.875 | 268.305 | 0,77% | Aktien |
| Invenomic Capital Management LP | $16.216.275 | 216.217 | 0,62% | Aktien |
| FMR LLC | $15.638.325 | 208.511 | 0,60% | Aktien |
| HEARTLAND ADVISORS INC | $15.000.000 | 200.000 | 0,58% | Aktien |
| GLENMEDE TRUST CO NA | $14.454.000 | 192.720 | 0,56% | Aktien |
| MORGAN STANLEY | $13.073.475 | 174.313 | 0,50% | Aktien |
| Longaeva Partners L.P. | $12.286.650 | 163.822 | 0,47% | Aktien |
| RHUMBLINE ADVISERS | $10.812.225 | 144.163 | 0,42% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $10.613.250 | 141.510 | 0,41% | Aktien |
| Balyasny Asset Management L.P. | $10.123.575 | 134.981 | 0,39% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $9.750.000 | 130.000 | 0,37% | Aktien |
| Point72 Asset Management, L.P. | $8.192.700 | 109.236 | 0,31% | Aktien |
| Verition Fund Management LLC | $7.913.100 | 105.508 | 0,30% | Aktien |
| ARIEL INVESTMENTS, LLC | $7.569.975 | 100.933 | 0,29% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $7.500.000 | 100.000 | 0,29% | Kaufoption |
| KESTREL INVESTMENT MANAGEMENT CORP | $7.305.000 | 97.400 | 0,28% | Aktien |
| Divisadero Street Capital Management, LP | $7.234.425 | 96.459 | 0,28% | Aktien |
| Swiss National Bank | $6.997.500 | 93.300 | 0,27% | Aktien |
| GOLDMAN SACHS GROUP INC | $6.750.000 | 90.000 | 0,26% | Kaufoption |
| GOLDMAN SACHS GROUP INC | $6.750.000 | 90.000 | 0,26% | Verkaufsoption |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6.510.000 | 86.800 | 0,25% | Kaufoption |
| Squarepoint Ops LLC | $6.459.300 | 86.124 | 0,25% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $6.215.025 | 82.867 | 0,24% | Aktien |
| Quantinno Capital Management LP | $5.477.550 | 73.034 | 0,21% | Aktien |
| ROYCE & ASSOCIATES LP | $5.360.625 | 71.475 | 0,21% | Aktien |
| AMERIPRISE FINANCIAL INC | $5.358.525 | 71.447 | 0,21% | Aktien |
| JUPITER ASSET MANAGEMENT LTD | $5.229.300 | 69.724 | 0,20% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $5.166.634 | 91.672 | 0,20% | Aktien |
| SEGALL BRYANT & HAMILL, LLC | $5.106.900 | 68.092 | 0,20% | Aktien |
| AMERICAN CAPITAL MANAGEMENT INC | $5.018.625 | 66.915 | 0,19% | Aktien |
| ISTHMUS PARTNERS, LLC | $4.946.325 | 65.951 | 0,19% | Aktien |
| Corient Private Wealth LP | $4.851.975 | 64.693 | 0,19% | Aktien |
| FIRST TRUST ADVISORS LP | $4.751.850 | 63.358 | 0,18% | Aktien |
| DEAN INVESTMENT ASSOCIATES, LLC | $4.649.175 | 61.989 | 0,18% | Aktien |
| PEREGRINE CAPITAL MANAGEMENT LLC | $4.497.450 | 59.966 | 0,17% | Aktien |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $4.484.325 | 59.791 | 0,17% | Aktien |
| Bridgewater Associates, LP | $4.479.975 | 59.733 | 0,17% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $4.181.475 | 55.753 | 0,16% | Aktien |
| Trexquant Investment LP | $3.946.425 | 52.619 | 0,15% | Aktien |
| Aequim Alternative Investments LP | $3.840.000 | 51.200 | 0,15% | Aktien |
| RICE HALL JAMES & ASSOCIATES, LLC | $3.827.850 | 51.038 | 0,15% | Aktien |
| JANE STREET GROUP, LLC | $3.682.500 | 49.100 | 0,14% | Kaufoption |
| MetLife Investment Management, LLC | $3.681.075 | 49.081 | 0,14% | Aktien |
| BlackRock, Inc. | $3.618.975 | 48.253 | 0,14% | Aktien |
| Retirement Systems of Alabama | $3.604.875 | 48.065 | 0,14% | Aktien |
| Riverwater Partners LLC | $3.573.375 | 47.645 | 0,14% | Aktien |
| Skylands Capital, LLC | $3.571.875 | 47.625 | 0,14% | Aktien |
| FIFTH THIRD BANCORP | $3.561.472 | 47.486 | 0,14% | Aktien |
| ALGERT GLOBAL LLC | $3.522.750 | 46.970 | 0,14% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $3.441.750 | 45.890 | 0,13% | Aktien |
| Qube Research & Technologies Ltd | $3.425.475 | 45.673 | 0,13% | Aktien |
| Dean Capital Management | $3.372.600 | 44.968 | 0,13% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $3.351.375 | 44.685 | 0,13% | Aktien |
| EASTERLY INVESTMENT PARTNERS LLC | $3.248.025 | 43.307 | 0,12% | Aktien |
| Phocas Financial Corp. | $3.227.250 | 43.030 | 0,12% | Aktien |
| ZB,N.A. | $3.200.968 | 40.996 | 0,12% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $3.190.200 | 42.536 | 0,12% | Aktien |
| CONNORS INVESTOR SERVICES INC | $3.150.000 | 42.000 | 0,12% | Aktien |
| Expect Equity LLC | $3.076.950 | 41.026 | 0,12% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $2.964.874 | 52.606 | 0,11% | Aktien |
| BEACON INVESTMENT ADVISORS LLC | $2.783.648 | 37.115 | 0,11% | Aktien |
| Campbell & CO Investment Adviser LLC | $2.763.300 | 36.844 | 0,11% | Aktien |
| Assenagon Asset Management S.A. | $2.633.175 | 35.109 | 0,10% | Aktien |
| BARCLAYS PLC | $2.448.300 | 32.644 | 0,09% | Aktien |
| MARSHALL WACE, LLP | $2.286.975 | 30.493 | 0,09% | Aktien |
| Cubist Systematic Strategies, LLC | $2.219.702 | 45.541 | 0,09% | Aktien |
| XTX Topco Ltd | $2.208.150 | 29.442 | 0,08% | Aktien |
| Legal & General Group Plc | $2.032.875 | 27.105 | 0,08% | Aktien |
| CARY STREET PARTNERS FINANCIAL LLC | $1.999.800 | 26.664 | 0,08% | Aktien |
| Nierenberg Investment Management Company, LLC | $1.971.000 | 26.280 | 0,08% | Aktien |
| Aurora Investment Counsel | $1.912.575 | 25.501 | 0,07% | Aktien |
| WESBANCO BANK INC | $1.912.500 | 25.500 | 0,07% | Aktien |
| Cardinal Capital Management | $1.861.275 | 24.817 | 0,07% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $1.846.275 | 24.617 | 0,07% | Aktien |
| Legato Capital Management LLC | $1.758.750 | 23.450 | 0,07% | Aktien |
| CITADEL ADVISORS LLC | $1.740.000 | 23.200 | 0,07% | Kaufoption |
Unternehmensinsider 72 Insider · 48 Führungskräfte · 25 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Christopher Simon, | President & CEO | 15. Mai 2026 A | 444.704 | 0 | 0 | $0 |
| Brian Concannon | President & CEO | 15. September 2015 M | 147.040 | 0 | 0 | $0 |
| James Darecca | EVP, Chief Financial Officer | 15. Mai 2026 A | 54.444 | 0 | 0 | $0 |
| William P. Mr. Burke | EVP, Chief Financial Officer | 23. August 2021 M | 30.291 | 0 | 0 | $0 |
| Christopher J Lindop | CFO & EVP Business Development | 13. Januar 2016 A | 56.743 | 0 | 0 | $0 |
| Ronald J Ryan | VP and CFO | 1. November 2006 P | 2.101 | 0 | 0 | $0 |
| Stewart W Strong | President, Global Hospital | 26. Juli 2024 S | 18.196 | 0 | 0 | $0 |
| Byron Selman | President, Global Markets | 25. Oktober 2016 A | 23.318 | 0 | 0 | $0 |
| Peter M Allen | President, Global Plasma | 6. Juli 2015 M | 34.102 | 0 | 0 | $0 |
| Kelly Michael P | President, Global Markets | 11. November 2013 M | 10.987 | 0 | 0 | $0 |
| Mikael Gordon | President, Global Markets | 3. Mai 2012 M | 4.442 | 0 | 0 | $0 |
| Remi Corlin | President, Asia | 8. August 2008 M | 884 | 0 | 0 | $0 |
| Keiko Hattori | President, Haemonetics Japan | 1. Mai 2008 P | 716 | 0 | 0 | $0 |
| Thomas Lawlor | President, Patient Division | 28. November 2007 M | 0 | 0 | 0 | $0 |
| Ryoji Sakai | President, Japan | 14. Juni 2007 M | 0 | 0 | 0 | $0 |
| Ulrich Eckert | President, Europe & Latin Am | 1. November 2006 P | 890 | 0 | 0 | $0 |
| Yutaka Sakurada | President, Japan & Asia | 2. Mai 2005 P | 2.347 | 0 | 0 | $0 |
| Frank Chan | EVP, Chief Operating Officer | 15. Mai 2026 A | 32.936 | 0 | 0 | $0 |
| Kent J Davies | Chief Operating Officer | 23. Oktober 2015 S | 16.891 | 0 | 0 | $0 |
| Farris Maryanne Maunsell | VP, Chief Accounting Officer | 5. Juni 2026 F | 6.242 | 0 | 0 | $0 |
| Laurie A. Miller | SVP, Human Resources | 5. Juni 2026 F | 40.987 | 0 | 0 | $0 |
| Roy Galvin | EVP, Chief Commercial Officer | 15. Mai 2026 A | 39.882 | 0 | 0 | $0 |
| Michelle L Basil | EVP and General Counsel | 15. Mai 2026 A | 68.829 | 0 | 0 | $0 |
| Anila Lingamneni | EVP, Chief Technology Officer | 12. Juli 2024 S | 21.331 | 0 | 0 | $0 |
| Josep Llorens | EVP, Global Manufacturing | 28. Mai 2024 F | 30.940 | 0 | 0 | $0 |
| Dan Goldstein | VP, Corporate Controller | 13. Juni 2022 S | 4.447 | 0 | 0 | $0 |
| Jacqueline Scanlan | SVP, Global Human Resources | 7. Juni 2021 S | 4.216 | 0 | 0 | $0 |
| Said Bolorforosh | EVP, Chief Technology Officer | 11. November 2019 S | 1.977 | 0 | 0 | $0 |
| Neil 122-62-507 Ryding | EVP, Global Manufacturing | 7. Juni 2018 S | 15.226 | 0 | 0 | $0 |
| David Fusco | EVP, Global Human Resources | 25. Oktober 2016 A | 16.867 | 0 | 0 | $0 |
| Sandra Jesse | EVP and Chief Legal Officer | 25. Oktober 2016 A | 48.166 | 0 | 0 | $0 |
| Jonathan White | Chief Science and Technology | 26. Oktober 2015 S | 30.507 | 0 | 0 | $0 |
| Susan M Hanlon | VP Finance | 26. Oktober 2015 S | 20.464 | 0 | 0 | $0 |
| Brian R Burns | EVP, Global QA/RA | 23. Oktober 2015 S | 16.235 | 0 | 0 | $0 |
| Dave Helsel | EVP, Global Manufacturing | 13. April 2015 D | 13.216 | 0 | 0 | $0 |
| Kathleen Mcdaniel | EVP Global Human Resources | 28. August 2014 S | 5.013 | 0 | 0 | $0 |
| Warren Nighan JR | EVP, Global QA/RA | 24. Juli 2013 A | 7.618 | 0 | 0 | $0 |
| Joseph J Forish | VP, Human Resources | 30. April 2013 P | 17.279 | 0 | 0 | $0 |
| Phillip John Brancazio | VP, Global Manufacturing | 4. Mai 2011 P | 3.052 | 0 | 0 | $0 |
| Alicia R Lopez | VP, Corporate Affairs | 5. April 2011 D | 2.815 | 0 | 0 | $0 |
| Michael I Ruxin | VP Global Software Strategies | 4. November 2010 P | 215 | 0 | 0 | $0 |
| Brad Nutter | Chairman of the Board | 29. Juli 2010 A | 10.580 | 0 | 0 | $0 |
| Robert B Ebbeling | Vice President, Operations | 1. Mai 2009 P | 15.849 | 0 | 0 | $0 |
| Jan Conneely | VP & GM, Arryx, Inc. | 1. Mai 2008 P | 1.041 | 0 | 0 | $0 |
| William Granville | VP, Manufacturing | 1. Mai 2008 P | 12.188 | 0 | 0 | $0 |
| Mark A Popovsky | VP, Corporate Medical Director | 1. Mai 2008 P | 4.891 | 0 | 0 | $0 |
| Stephen Swenson | VP & General Mgr, Global Plasm | 1. Mai 2008 P | 3.024 | 0 | 0 | $0 |
| William Roche Still | VP & Gen Mrg, Therapeutics Bus | 4. Mai 2007 M | 4.193 | 0 | 0 | $0 |
| Lloyd Emerson Johnson | Direktor | 24. Juli 2026 A | 15.471 | 0 | 0 | $0 |
| Diane M Bryant | Direktor | 24. Juli 2026 A | 9.664 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 8 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 6. Februar 2004 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 20. August 2003 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 8. August 2003 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 24. Juni 2003 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 19. Juni 2003 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 3. Juni 2003 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 27. Mai 2003 | — | Erste Einreichung | — | SEC |
| Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter, Nicht offengelegter meldender Beteiligter | 15. Juni 2001 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 87 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| NBSM · Neuberger Berman ETF Trust | 1,86% | 61.981 NS | 31. Mai 2026 | N-PORT |
| JSML · Janus Detroit Street Trust | 0,84% | 43.927 NS | 30. April 2026 | N-PORT |
| JSMD · Janus Detroit Street Trust | 0,77% | 125.093 NS | 30. April 2026 | N-PORT |
| ROSC · Lattice Strategies Trust | 0,64% | 5.836 NS | 30. April 2026 | N-PORT |
| SIXL · EXCHANGE TRADED CONCEPTS TRUST | 0,46% | 12.701 NS | 31. Mai 2026 | N-PORT |
| CALF · Pacer Funds Trust | 0,35% | 201.070 NS | 30. April 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,32% | 35.814 NS | 31. Mai 2026 | N-PORT |
| ABCS · EA Series Trust | 0,31% | 522 NS | 29. Mai 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,24% | 41.437 NS | 30. April 2026 | N-PORT |
| IWO · iShares Trust | 0,23% | 402.938 SH | 8. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,23% | 75.831 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,20% | 47.624 SH | 8. August 2026 | Täglich |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,19% | 76.694 NS | 31. Mai 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,14% | 17.393 NS | 30. April 2026 | N-PORT |
| MIDE · DBX ETF Trust | 0,13% | 63 NS | 29. Mai 2026 | N-PORT |
| IJK · iShares Trust | 0,13% | 163.140 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,13% | 1.201.903 SH | 8. August 2026 | Täglich |
| BKSE · BNY Mellon ETF Trust | 0,13% | 1.703 NS | 30. April 2026 | N-PORT |
| XJH · iShares Trust | 0,12% | 6.299 SH | 8. August 2026 | Täglich |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,12% | 12.097 NS | 30. April 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,12% | 24.558 SH | 8. August 2026 | Täglich |
| SMDX · Tidal Trust III | 0,12% | 2.419 NS | 30. April 2026 | N-PORT |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,11% | 27.512 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,11% | 271.486 SH | 8. August 2026 | Täglich |
| NUSC · Nushares ETF Trust | 0,11% | 23.551 NS | 30. April 2026 | N-PORT |
| IJH · iShares Trust | 0,11% | 1.603.400 SH | 8. August 2026 | Täglich |
| FSMD · FIDELITY COVINGTON TRUST | 0,11% | 42.163 NS | 30. April 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,11% | 5.312 SH | 8. August 2026 | Täglich |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,10% | 74.976 SH | 8. August 2026 | Täglich |
| FNDA · SCHWAB STRATEGIC TRUST | 0,10% | 126.817 NS | 31. Mai 2026 | N-PORT |
| IJJ · iShares Trust | 0,09% | 94.775 SH | 8. August 2026 | Täglich |
| EBIT · Harbor ETF Trust | 0,09% | 168 NS | 30. April 2026 | N-PORT |
| ESML · iShares Trust | 0,09% | 29.374 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,09% | 20.324 NS | 30. April 2026 | N-PORT |
| IVOV · VANGUARD ADMIRAL FUNDS | 0,08% | 15.968 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,08% | 2.210 NS | 31. Mai 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,08% | 5.212 NS | 30. April 2026 | N-PORT |
| ISCV · iShares Trust | 0,07% | 6.131 SH | 8. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,07% | 159.737 NS | 30. April 2026 | N-PORT |
| MVV · ProShares Trust | 0,07% | 1.606 NS | 31. Mai 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,07% | 222.776 NS | 31. Mai 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,06% | 12.283 NS | 30. April 2026 | N-PORT |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,06% | 9.034 SH | 8. August 2026 | Täglich |
| ISCB · iShares Trust | 0,06% | 1.979 SH | 8. August 2026 | Täglich |
| SMLF · iShares Trust | 0,06% | 28.701 SH | 8. August 2026 | Täglich |
| MIDU · Direxion Shares ETF Trust | 0,06% | 770 NS | 30. April 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,05% | 2.220 NS | 31. Mai 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,05% | 1.979 NS | 31. Mai 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,05% | 302.003 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,05% | 139.826 SH | 8. August 2026 | Täglich |